Can standard genotoxicity tests be applied to nanoparticles?

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 75, Issue 13-15, 2012, Pages 800-806

  Magdolenova, Zuzana ^a   Lorenzo, Yolanda ^b   Collins, Andrew ^b   Dusinska, Maria ^a  

^a NORWEGIAN INSTITUTE FOR AIR RESEARCH   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYGUANINE; CYTOCHALASIN B; DNA FORMAMIDOPYRIMIDINE GLYCOSYLASE; ENDONUCLEASE; MAGNETITE; NANOPARTICLE; PURINE DERIVATIVE; TITANIUM DIOXIDE;

ANIMAL CELL; CELL DIVISION; CONFERENCE PAPER; DNA DAMAGE; DNA STRAND BREAKAGE; ENDOCYTOSIS; FIBROBLAST; GENOTOXICITY; IN VITRO STUDY; MICRONUCLEUS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CERCOPITHECUS AETHIOPS; CHROMOSOME ABERRATIONS; COMET ASSAY; COS CELLS; CYTOCHALASIN B; DNA; DNA BREAKS; DNA-FORMAMIDOPYRIMIDINE GLYCOSYLASE; ENDOCYTOSIS; ENDONUCLEASES; HELA CELLS; HUMANS; MATERIALS TESTING; METAL NANOPARTICLES; MICRONUCLEUS TESTS; NANOPARTICLES; NEOPLASM PROTEINS; PARTICLE SIZE; TOXICITY TESTS;

EID: 84864075558     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287394.2012.690326     Document Type: Conference Paper

References (14)

1. Collins, A. R. 2004. The comet assay for DNA damage and repair: Principles, applications, and limitations. Mol. Biotechnol., 26: 249-61.
2. EFSA Scientific Committee. 2011. Guidance on the risk assessment of the application of nanoscience and nanotechnologies in the food and feed chain. EFSA J., 9: 2140-76.
3. Damoiseaux, R., George, S., Li, M., Pokhrel, S., Ji, Z., France, B., Xia, T., Suarez, E., Rallo, R., Mdler, L., Cohen, Y., Hoek, E. M., and, Nel, A. 2011. No time to loseHigh throughput screening to assess nanomaterial safety. Nanoscale, 3: 1345-60.
4. Fenech, M. 1997. The advantages and disadvantages of the cytokinesis-block micronucleus method. Mutat. Res., 392: 11-18.
5. Fenech, M. 2000. The in vitro micronucleus technique. Mutat. Res., 455: 81-95.
6. Fenech, M., Chang, W.P., Kirsch-Volders, M., Holland, N., Bonassi, S., and, Zeiger, E. 2003. HUMN project: Detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. Mutat. Res., 534: 65-75.
7. Karlsson, H. L. 2010. The comet assay in nanotoxicology research. Anal. Bioanal. Chem., 398: 651-66.
8. Kroll, A., Pillukat, M. H., Hahn, D., and, Schnekenburger, J. 2009. Current in vitro methods in nanoparticle risk assessment: Limitations and challenges. Eur. J. Pharm. Biopharm., 72: 370-77.
9. Magdolenova, Z, Bilanicova, D, Pojana, G, Fjellsb, LM, Hudecova, A, Hasplova, K, Marcomini, A, and, Dusinska, M. 2012. Impact of agglomeration and different dispersions of titanium dioxide nanoparticles on the human related in vitro cytotoxicity and genotoxicity. J. Environ. Monit, 14: 455-64.
10. Maynard, A. D., Warheit, D. B., and, Philbert, M. A. 2011. The new toxicology of sophisticated materials: nanotoxicology and beyond. Toxicol. Sci., 120 (suppl. 1): S109-29.
11. Oberdrster, G., Maynard, A., Donaldson, K., Castranova, V., Fitzpatrick, J., Ausman, K., Carter, J., Karn, B., Kreyling, W., Lai, D., Olin, S., Monteiro-Riviere, N., Warheit, D., and, Yang, H. 2005. ILSI Research Foundation/Risk Science Institute Nanomaterial Toxicity Screening Working Group. Principles for characterizing the potential human health effects from exposure to nanomaterials: Elements of a screening strategy. Part. Fibre Toxicol., 2: 8
12. Scientific Committee on Emerging and Newly-Identified Health Risks. 2009. Health effects of exposure to EMF, Brussels, Belgium: European Commission.
13. Stone, V., Johnston, H., and, Schins, R. P. 2009. Development of in vitro systems for nanotoxicology: Methodological considerations. Crit. Rev. Toxicol., 39: 613-26.
14. Zhao, J., and, Castranova, V. 2011. Toxicology of nanomaterials used in medicince. J. Toxicol. Environ. Health B, 14: 593-632.